GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study
29 juil. 2019 09h00 HE
|
GeoVax, Inc.
Study Data Adds to Similar Efficacy Previously Reported for GeoVax’s Ebola and Lassa Fever Vaccines ATLANTA, GA, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...